Dong-Soo Lee

Dong-Soo Lee


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in World Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
HAHyo Jun Ahn
Hyo Jun Ahn
DLDong-Soo Lee
Dong-Soo Lee
Helicobacter pylori in gastric carcinogenesis

27 August 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JLJin-Seok Lee
Jin-Seok Lee
Hyeong-Geug KimHyeong-Geug Kim
Hyeong-Geug Kim
DLDong-Soo Lee
Dong-Soo Lee
Chang Gue SonChang Gue Son
Chang Gue Son
The linkage between oxidative stress and idiopathic chronic fatigue (ICF) has not been explored in detail. This study thoroughly compared the serum levels of biomarkers for oxidative stress and antioxidants from 103 subjects with ICF (20 men and 83 women) to those of 82 healthy volunteers (27 men and 55 women). Oxidative parameters, which included reactive oxygen species (ROS), malondialdehyde (MDA) and F2-isoprotan, and tumor necrosis factor-alpha (TNF-α) were significantly elevated, while antioxidant parameters, which included total antioxidant activity (TAC), catalase, superoxide dismutase, SOD and GSH activity, were decreased compared to those of healthy subjects (by approximately 1.2- to 2.3-fold, p < 0.05 or 0.01). Our results confirmed that oxidative stress is a key contributor in the pathophysiology of ICF, and firstly explored the features of oxidative stress parameters in ICF subjects compared to a healthy population.

1 January 2008 in World Journal of Gastroenterology
Verified
Journal Article
Open access
SLSeung-Woo Lee
Seung-Woo Lee
CSChun-Young Song
Chun-Young Song
YGYoung-Hwa Gi
Young-Hwa Gi
SKSang-Beom Kang
Sang-Beom Kang
YKYon-Soo Kim
Yon-Soo Kim
JKJong-Ok Kim
Jong-Ok Kim
Hepatic angiosarcoma manifested as recurrent hemoperitoneum

5 January 2013 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
BCByung-Joon Chun
Byung-Joon Chun
DLDong-Soo Lee
Dong-Soo Lee

1 December 2014 in Cancer Letters
Verified
Journal Article
Closed access
SZSonghua Zhang
Songhua Zhang
DLDong-Soo Lee
Dong-Soo Lee
RMRhiannon Morrissey
Rhiannon Morrissey
JAJose R. Aponte-Pieras
Jose R. Aponte-Pieras
ARArlin B. Rogers
Arlin B. Rogers
SMSteven F. Moss
Steven F. Moss

1 December 2016 in The Journal of Alternative and Complementary Medicine
Verified
Journal Article
Closed access
SCSeung-Hwa Choi
Seung-Hwa Choi
KYKeum-Jin Yang
Keum-Jin Yang
DLDong-Soo Lee
Dong-Soo Lee
Objectives: Chronic hepatitis B management is commonly targeted at reducing viral replication. However, the currently available antiviral therapies are associated with some problems, including resistance and numerous adverse effects. Ginseng has been reported to be effective for treating viral infections such as influenza and human immunodeficiency virus. However, there are currently few studies on the effects of ginseng in chronic hepatitis B. Thus, this study investigated the effects of ginseng together with antiviral agents in chronic hepatitis B. Subjects and methods: This was a prospective, single-blinded, randomized controlled trial, and single-center study. Thirty-eight patients were enrolled. The control group (n = 19) was administered antiviral agents alone. The experimental group (n = 19) was administered antiviral agents along with Korean Red Ginseng powder capsules (each dose is 1 gram (two capsules), a one-day dose is 3 grams). The baseline characteristics did not differ between the two groups. Differences in several non-invasive fibrosis serologic markers (type IV collagen, hyaluronic acid, transforming growth factor-β) and in the hepatitis B virus DNA levels were compared between the groups. Results: The non-invasive fibrosis serologic markers were further decreased in the experimental group, with significant differences after treatment observed for hyaluronic acid (p = 0.032) and transforming growth factor-β (p = 0.008), but not for type IV collagen (p = 0.174). Conclusions: This study suggests the possibility of Korean Red Ginseng as a complementary therapy for chronic hepatitis B.